Avdoralimab an Anti-C5aR Antibody, in Patients With COVID-19 Severe Pneumonia ( FORCE )

NCT04371367 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

208

Enrollment

OTHER

Sponsor class

Conditions

COVID

Interventions

BIOLOGICAL: avdoralimab
OTHER: Placebo

Sponsor

Assistance Publique Hopitaux De Marseille

Collaborators

[object Object]